Section 337 Exclusion Orders for New Technology: Examining Public Interest Concerns Potentially Arising from Exclusion Orders – Case Study on Biologics
What is it about?
CASE STUDY ON BIOLOGICS
- Exploring the unique public interest issues that arise for different technologies, such as 5G mobile phone technology and biologics products
- Understanding how the Commission has been adapting to new technologies through an increase in the issuance of tailored remedies to address unique public interest concerns
- Examining whether the same public interest issues that could arise in cases involving biologics could be raised in cases involving biosimilars